Lisa Olson
Chief Executive Officer bij Enthera Srl
Vermogen: 26 760 $ op 31-03-2024
Profiel
Lisa M.
Olson is currently the Chief Executive Officer at Enthera Srl, Director at Lassen Therapeutics 1, Inc., and an Assistant Professor at Washington University School of Law.
Previously, she was a Director at Enthera.
Srl, Vice President-Immunology Discovery at AbbVie Bioresearch Center, Inc., and the Chief Scientific Officer & Head-Research at Magenta Therapeutics, Inc. She received her undergraduate degree from Iowa State University and her doctorate from the University of Illinois At Urbana–Champaign.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2023 | 892 ( 0.00% ) | 26 760 $ | 31-03-2024 |
Actieve functies van Lisa Olson
| Bedrijven | Functie | Begin |
|---|---|---|
| Washington University School of Law | Corporate Officer/Principal | - |
Lassen Therapeutics 1, Inc.
 Lassen Therapeutics 1, Inc. Pharmaceuticals: MajorHealth Technology Lassen Therapeutics 1, Inc. develops pharmaceuticals. The company was founded by David King John and is headquartered in San Diego, CA. | Director/Board Member | 07-10-2021 |
Enthera Srl
 Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Chief Executive Officer | 23-01-2024 |
Eerdere bekende functies van Lisa Olson
| Bedrijven | Functie | Einde |
|---|---|---|
| MAGENTA THERAPEUTICS | Chief Tech/Sci/R&D Officer | 15-05-2023 |
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Director/Board Member | - |
| AbbVie Bioresearch Center, Inc. | Corporate Officer/Principal | - |
Opleiding van Lisa Olson
| Iowa State University | Undergraduate Degree |
| University of Illinois At Urbana–Champaign | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
| AbbVie Bioresearch Center, Inc. | |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Health Technology |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. Pharmaceuticals: MajorHealth Technology Lassen Therapeutics 1, Inc. develops pharmaceuticals. The company was founded by David King John and is headquartered in San Diego, CA. | Health Technology |
